Why is OpenAI’s language generator GPT-3 such a hot topic? We were wondering too. Please join us as we learn together why there is all the buzz, what the fundamentals of OpenAI/GPT-3 are and how clinical trials can benefit. This is a fast, easy way to be in-the-know on an emerging technology that could have a fundamental impact on the future of clinical operations.

Specifically, in this webinar TrialSpark CEO and Founder, Dr Ben Liu, will cover:

– The GPT-3 model and its capabilities for broad application
– A step-by-step demonstration of GPT-3 turning a protocol into an FDA-regulated auto-generated eCRF
– The potential implications and alternate use cases for clinical trials, including other features in pilot that are sales-accretive

Click here for additional information and registration details.

Related Content

Evidence Matters 2022

Evidence Matters 2022

Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.